Gastrointestinal Cancer News

In 2021, an estimated 16,500 Hispanic men and women were diagnosed with cancer of the colon or rectum and about 4,700 Hispanic individuals died from the disease.

Trifluridine-tipiracil plus bevacizumab was not superior to capecitabine plus bevacizumab but presented no new safety concerns in patients with unresectable metastatic colorectal cancer who are ineligible for intensive treatment.

Certain fungal species in tumors may be associated with worse cancer outcomes, according to a study conducted by researchers at Weill Cornell Medicine and Duke University and published in the journal Cell.

A plant-based diet rich in whole grains, vegetable and legumes was associated with a reduced risk for colorectal cancer in a multiethnic cohort of men but varied by race, ethnicity and site of tumor, according to research in BMC Medicine.

An increasing number of oral anticancer drugs have been granted FDA approval and introduced into clinical practice.

Zanidatamab monotherapy appeared active among patients with HER2-amplified and -expressing biliary tract cancer, according to the agent’s manufacturer.

The addition of zolbetuximab to chemotherapy improved PFS among certain patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma, according to the agent’s manufacturer.

Genomic testing continues to provide oncologists with a wealth of meaningful, treatment-guiding information for a growing number of cancers.

Use of artificial intelligence in medical imaging has increased rapidly across health care specialties, and oncology is no exception.

Perioperative complication rates were similar between simultaneous and delayed resection of liver metastasis and colorectal cancer, although survival benefits of simultaneous resection were greater in patients with KRAS wild-type tumors.